Nagpal Neha, Agarwal Suneet
Division of Hematology/Oncology and Stem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Stem Cells. 2020 Sep 1. doi: 10.1002/stem.3270.
Telomeres are composed of repetitive DNA sequences that are replenished by the enzyme telomerase to maintain the self-renewal capacity of stem cells. The RNA component of human telomerase (TERC) is the essential template for repeat addition by the telomerase reverse transcriptase (TERT), and also serves as a scaffold for several factors comprising the telomerase ribonucleoprotein (RNP). Unique features of TERC regulation and function have been informed not only through biochemical studies but also through human genetics. Disease-causing mutations impact TERC biogenesis at several levels including RNA transcription, post-transcriptional processing, folding, RNP assembly, and trafficking. Defects in TERC reduce telomerase activity and impair telomere maintenance, thereby causing a spectrum of degenerative diseases called telomere biology disorders (TBDs). Deciphering mechanisms of TERC dysregulation have led to a broader understanding of noncoding RNA biology, and more recently points to new therapeutic strategies for TBDs. In this review, we summarize over two decades of work revealing mechanisms of human telomerase RNA biogenesis, and how its disruption causes human diseases.
端粒由重复的DNA序列组成,这些序列由端粒酶补充以维持干细胞的自我更新能力。人端粒酶的RNA组分(TERC)是端粒酶逆转录酶(TERT)进行重复添加的必需模板,并且还作为构成端粒酶核糖核蛋白(RNP)的几种因子的支架。TERC调控和功能的独特特征不仅通过生化研究,也通过人类遗传学得以揭示。致病突变在几个层面影响TERC生物合成,包括RNA转录、转录后加工、折叠、RNP组装和运输。TERC缺陷会降低端粒酶活性并损害端粒维持,从而导致一系列称为端粒生物学障碍(TBD)的退行性疾病。对TERC失调机制的解读使人们对非编码RNA生物学有了更广泛的理解,并且最近还指向了TBD的新治疗策略。在本综述中,我们总结了二十多年来揭示人端粒酶RNA生物合成机制以及其破坏如何导致人类疾病的研究工作。